I am one of those who knows nothing about Cancer and its treatment...
However, I do know a good business case when I seen one.
...and we all already know Bisantrene is safe for use in humans.
So the only question is how many cancers can Bisantrene treat?
I read 15% to 25% of all cancers have FTO overexpressed
I have no idea what that means except it seems the FTO is allowing the cancer to grow
i.e. kill the FTO and the Cancer cannot survive
Then there is other specific benefits, e.g. AML etc
In reality it seems Bisantrene was only made viable by a shift in Cancer treatment from single drug dosages to combination drug dosages in the past 5 years. ...and thank God for that because it seems we can treat many more people and return them to their loved ones.
MST valuation of RAC, page-266
-
- There are more pages in this discussion • 31 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.94 |
Change
0.055(2.92%) |
Mkt cap ! $330.4M | |||
| Open | High | Low | Value | Volume |
| $1.89 | $1.96 | $1.85 | $333.0K | 174.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3105 | $1.94 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.95 | 7574 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |